Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2003
06/05/2003WO2003045406A1 An chinese medicinal formulation treating stomachache, rib-side pain, headache and menstrual pain
06/05/2003WO2003045404A2 Treatment and diagnosis of diseases associated with adverse levels of zinc, cadmium and calcium
06/05/2003WO2003045394A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
06/05/2003WO2003045392A2 Use of n-(indolcarbonyl-)piperazine derivatives
06/05/2003WO2003045388A1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
06/05/2003WO2003045386A1 Benzothiazole derivatives
06/05/2003WO2003045385A1 Benzothiazole derivatives
06/05/2003WO2003045384A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045378A1 Amino acid derivatives useful for the treatment of alzheimer's disease
06/05/2003WO2003045375A1 Novel utilization of cyclopentabenzofurans
06/05/2003WO2003045369A2 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses
06/05/2003WO2003045368A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003WO2003045362A2 Treatment of th1 dominated immunological disease states with non-endogenous gestagen compounds
06/05/2003WO2003045328A2 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045316A2 Polynucleotide therapy
06/05/2003WO2003045315A2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003WO2003045228A2 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003WO2003045137A1 Method of constructing spinal injury model monkey and utilization thereof
06/05/2003WO2003045136A1 Disruption of the prostaglandin e synthase 2 gene
06/05/2003WO2003032974A3 Use of sulfonamide derivatives as pharmaceuticals compounds
06/05/2003WO2003024478A9 Treatment of central nervous system disorders by use of pdgf or vegf
06/05/2003WO2003005951A3 Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
06/05/2003WO2003004526A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines
06/05/2003WO2002099118A3 Method of identifying a polymorphism in cyp2d6
06/05/2003WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/05/2003WO2002062841A3 Secreted proteins
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003WO2002042330A3 Cystoskeleton-associated proteins
06/05/2003US20030106085 Disruption of the prostaglandin E synthase 2 gene
06/05/2003US20030106082 Transgenic stem cells, formed by dissociating blastomeres, are cultured, impregnated within surrogate; animals models; gene therapy
06/05/2003US20030105359 Having good thermal stability and/or solubility characterisitics
06/05/2003US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105302 Fibroblast cell growth factor; for diagnosis, detection and prevention of skin, cancer, brain, glandular, cell differentiation/ proliferative and placental disorders; antiproliferative agents, antitumor agents
06/05/2003US20030105168 Composition comprising ubiquinone
06/05/2003US20030105165 Gap junctions and EDHF
06/05/2003US20030105161 Analgesics; antiinflamamtory agents
06/05/2003US20030105159 Kavalactone compositions and methods of use
06/05/2003US20030105150 Method of treating of demyelinating diseases or conditions
06/05/2003US20030105149 Enhancement of learning and memory and treatment of amnesia
06/05/2003US20030105148 Selective estrogen receptor modulators
06/05/2003US20030105147 Analgesics, sedatives, anesthetics
06/05/2003US20030105144 Celecoxib dissolving in polyethylene glycol; antiinflammatory agents, osteoporosis, respiratory system disorders, antitumor agents, analgesics
06/05/2003US20030105141 Mixture containing fatty acid and aromatic amine; administering by mouth; cyclooxygenase enzyme inhibitor
06/05/2003US20030105139 Indole derivatives as 5-HT receptor antagonist
06/05/2003US20030105135 Adrenergic receptors; gastrointestinal disorders, dietetics, urogenital disorders, antidiabetic agents
06/05/2003US20030105133 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists
06/05/2003US20030105125 Tropane analogs and methods for inhibition of monoamine transport
06/05/2003US20030105123 For therapy of respiratory system disorders
06/05/2003US20030105118 Tricyclic quinazolinediones
06/05/2003US20030105117 For therapy of affective disorder, anxiety, depression, headache, irritable bowel syndrome, post-traumatic stress stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease, gastrointestinal diseases, anorexia
06/05/2003US20030105114 Methods of treatment and kits comprising a growth hormone secretagogue
06/05/2003US20030105113 Enantiomers of 1-[ (4-chlorophenyl) phenylmethyl ] -4-[ (4-methylphenyl) sulfonyl ] piperazine
06/05/2003US20030105112 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
06/05/2003US20030105110 Novel compounds
06/05/2003US20030105107 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105096 Serotonin transport inhibitors
06/05/2003US20030105095 4'-Methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
06/05/2003US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105089 Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
06/05/2003US20030105088 Thiol-based NAALADase inhibitors
06/05/2003US20030105087 New polycyclic azaindole compounds
06/05/2003US20030105083 Drug combination for the treatment of depression and related disorders comprising mirtazapine
06/05/2003US20030105081 Heterocyclic compounds as ligands of the GABAA receptor
06/05/2003US20030105079 Novel phenylalkyl diamine and amide analogs
06/05/2003US20030105075 Hymenialdisine or derivatives thereof in the manufacture of medicaments
06/05/2003US20030105031 Administering therapeutically effective amount of one or more flavonoids and carrier for therapy of reactive and inflammatory dermatoses
06/05/2003US20030105027 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
06/05/2003US20030104995 Neuroprotective methods and compositions
06/05/2003US20030104992 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
06/05/2003US20030104980 Treating sexual desire disorders with flibanserin
06/05/2003US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors)
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104516 Protein kinase npk-110
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104450 Novel regulator of g protein signalling
06/05/2003US20030104403 Nucleotide sequence coding transferase enzyme for use in treatment cancer
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030103959 Methods of providing neuroprotection and/or neurorestoration via the neural activin type IIB receptor
06/05/2003US20030103957 Comprises adenosine-diphosphate transferase activity; drug delivery; for suppressing inhibition of neuronal axon growth
06/05/2003US20030103954 Comprises vitamin D3 for regulating cell differentiation and/or cell proliferation
06/05/2003US20030103953 Comprises vitamin D3 for controlling cell differentiation and/or cell proliferation
06/05/2003US20030103949 Cell proliferation
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003CA2563052A1 Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.02,11.0 4,9]-hexadeca-2(11)3,5,7,9-pentaene
06/05/2003CA2477585A1 Amino acid derivatives useful for the treatment of alzheimer's disease
06/05/2003CA2468878A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their productionor generation
06/05/2003CA2468717A1 Aryl fused azapolycyclic compounds
06/05/2003CA2468705A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
06/05/2003CA2468380A1 Use of n-(indolecarbonyl)piperazine derivatives
06/05/2003CA2468292A1 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
06/05/2003CA2468280A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468159A1 4-aminoquinoline compounds
1 ... 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 ... 1833